Clinical Trial Update: Allogenic Stem Cell Therapy in Patients With Acute Burn [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on allogenic stem cell therapy for acute burns, spanning Phase 1 and Phase 2, sponsored by Shenzhen Beike Bio-Technology Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Allogenic Stem Cell Therapy

Snippet

Sponsor: Shenzhen Beike Bio-Technology Co., Ltd. | Conditions: Burns | Phase 1, Phase 2 | Status: UNKNOWN